Table 2.
Prevalence of Secondary Nutritional Impact Symptoms and Their Treatment
| Nutrition impact symptoms | Number (%) | Corresponding interventions | Number (% treated among effected individuals) |
|---|---|---|---|
| Early satiety | 94 (62%) | Metoclopramide | 74 (79%) |
| Constipation | 78 (52%) | Laxatives | 68 (87%) |
| Nausea or vomiting | 67 (44%) | Antiemetics (mostly metoclopramide) | 54 (81%) |
| Depressed mood | 63 (42%) | Antidepressant (mostly mirtazapine) | 51 (81%) |
| Dysgeusia | 42 (28%) | Zinc supplement | 20 (48%) |
| Dysphagia | 21 (14%) | GI or speech therapy evaluation | 5 (24%) |
| Dry mouth | 14 (9%) | Artificial saliva | 2 (14%) |
| Mucositis | 11 (7%) | Opioids and topical mouthwash | 3 (27%) |
| Dental pain | 8 (5%) | Dental referral | 2 (25%) |